Thursday, September 13, 2007

Immune System / Vaccines News
A Large-Scale Research Project By A Dutch Consortium Addressing A Global Problem
A new and promising research project of Top Institute Pharma is being conducted by a multi-member Dutch consortium with expertise in the fields of virology, immunology and vaccine development.
Sinovac Commences Vaccination On Volunteers For Phase II Clinical Trial On Pandemic Influenza H5N1 Vaccine
Sinovac Biotech Ltd. (Amex: SVA), a leading China-based biopharmaceutical company focusing on human vaccine development, announced that it has commenced vaccination of volunteers for its Phase II clinical research study of its pandemic influenza H5N1 vaccine.
Understanding How Antibodies Fight HIV May Further Efforts To Create AIDS Vaccine
By furthering scientists' understanding of the molecular mechanisms that separate the minority of successful HIV antibodies from the majority of ineffective antibodies, the work may have implications for future attempts to design an HIV vaccine.

0 Comments:

Post a Comment

<< Home